Dillico
June 22, 2026
Theater 3
Type: Company Presentation
Focus Area:
Tools/Drug Development Support Tech
Dillico developed the All-ScaleFlow manufacturing platform, an end-to-end automated continuous production equipment for m/sa/gRNA-LNP therapeutics with related digital tools and services. This solution enables efficient in-silico process development for any mRNA therapeutics, leveraging a Performance Modeling Platform. The continuous production is scale-up free and can process batches ranging from pre-clinical or individualized medicine scale to large commercial scale. The All-ScaleFlow is a powerful tool to accelerate the advancement of m/sa/gRNA assets through the pipeline.
Company HQ City:
Meylan
Company HQ State:
-
Company HQ Country:
France
Year Founded:
2022
Lead Product in Development:
All-ScaleFlow
CEO
Christophe BONNEVILLE, PhD
Development Phase of Lead Product
Other/Not Applicable
Number of Unlicensed Products Looking for Licensing
0
When you expect your next catalyst update?
07/2027
What is your next catalyst (value inflection) update?
1st delivery of All-ScaleFlow equipment (equipment worth several million)
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}